Table_4.xls (5.5 kB)
Comparison of chemosensitivity between primary site and liver metastasis in CD-DST.
dataset
posted on 2013-08-28, 01:40 authored by Katsushi Takebayashi, Eiji Mekata, Hiromichi Sonoda, Tomoharu Shimizu, Hisanori Shiomi, Shigeyuki Naka, Yoshihiro Endo, Tohru Tani5-FU, 5-fluorouracil; SN38, the active metabolite of irinotecan; OHP, the active metabolite of oxaliplatin.
There was no significant difference in chemosensitivity when comparing the liver metastasis and the primary tumor.
*statistical significance.
